September 15, 2019 | English | عربي
   Add to Twitter
 
Samsung Bioepis Continues Global Expansion, Enters Brazilian Biopharmaceutical Market with BRENZYS™ (etanercept)
Samsung Bioepis’ BRENZYS™ (etanercept) becomes available in Brazil through Brazil’s public health system, Sistema Único de Saúde (SUS)

Established seven years ago, Samsung Bioepis’ products are now available across five continents: North America, Europe, Asia, Oceania, and Latin America.